Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade 
Gold Prices Rebound in Europe as Geopolitical Tensions and Fed Outlook Support Bullion 
Oil Prices Rise as Ukraine Peace Talks and Middle East Tensions Stir Supply Concerns 
Asian Markets End Year on AI Optimism as Precious Metals and Currencies Shine 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
As the Black Summer megafires neared, people rallied to save wildlife and domestic animals. But it came at a real cost 
How to create a thriving forest, not box-checking ‘tree cover’ 
Parasites are ecological dark matter – and they need protecting 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
An unexpected anomaly was found in the Pacific Ocean – and it could be a global time marker 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
LA fires: Long-term exposure to wildfire smoke is poorly understood − and a growing risk 
AB InBev would sell at "very low" prices or even give away the spent grains left over from the brewing process that could be converted to protein to help address increasing global food and sustainability challenges,
After three years working with AB InBev, the startup EverGrain has developed ingredients used in protein shakes and bars, bread, and barley milk.
With a new factory slated to open in St. Louis in March, AB InBev says expects EverGrain to haul in $20 million next year.
ZX Ventures is also hoping to leverage AB InBev's fermentation knowledge to scale up the production of alternative proteins through its company BioBrew.
Bernardo Novick, the global head of the AB InBev incubator ZX Ventures, emphasized that no one in the world possesses as much scaled fermentation knowledge as ABI. He added that the application of biotechnology to food and beverage is expected to be a massive opportunity in the next 10 to 20 years.
He noted that the market for alternative fermented protein alone is estimated to reach $22 billion by 2035.
But Novick admitted that BioBrew is still in exploratory spaces as to the kinds of products it could produce.
According to AB InBev CEO Michel Doukeris, the company pledged to combine its brewing infrastructure and expertise with biotech advancements to help address increasing global food and sustainability challenges.
He added that the company can leverage its core brewing and fermentation capabilities in new and exciting ways.
AB InBev expects $57 billion in sales for 2022.
